Butabarbital sodium 30 mg Oral Tablet
RxNorm 1251614
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1251614 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: butabarbital sodium 30 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Butabarbital sodium 30 mg Oral Tablet
(Atom ID: 12345537)
PSN
Prescribable Name (PSN):
Butabarbital sodium 30 mg Oral Tablet
(Atom ID: 6359878)
PT
Designated preferred name (PT):
Butabarbital sodium 30 mg oral tablet
(Atom ID: 9249206)
FN
Full form of descriptor (FN):
Product containing precisely secbutabarbital sodium 30 mg/1 each conventional release oral tablet (clinical drug)
(Atom ID: 10317107)
SY
Synonym (SY):
Secbutabarbital sodium 30 mg oral tablet
(Atom ID: 9264618)
Patient Education
Butabarbital
Butabarbital is used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep). It is also used to relieve anxiety, including anxiety before surgery. Butabarbital is in a class of medications called barbiturates. It works by slowing activity in the brain.
[Learn More]
* Please review the disclaimer below.